Skip to main content
. 2022 Feb 15;130(2):027008. doi: 10.1289/EHP9297

Figure 1.

Figure 1A is a set of four Estrogen Receptor alpha immunolabeled images depicting untreated M C F-7 breast cancer cells. Figure 1B is a horizontal heatmap, plotting fraction of the population, ranging from 0 to 0.26 in increments of 0.25 (left y-axis) and E X P 01, E X P 02, E X P 03, E X P 04, E X P 05, E X P 06, E X P 07, E X P 08, E X P 09, E X P 10, E X P 11, E X P 12, E X P 13, E X P 14, E X P 15, E X P 16, E X P 17, E X P 18 underscore 1, E X P 18 underscore 2, E X P 19, E X P 20, E X P 21, E X P 22, E X P 23, E X P 24, E X P 25, E X P 26 underscore 1, E X P 26 underscore 2, E X P 27 underscore 1, E X P 27 underscore 2, E X P 28, E X P 29, and E X P 30 (right y-axis) across Estrogen Receptor level (x-axis). Figure 1 C is a hierarchical clustering graph, plotting E X P 21, E X P 05, E X P 04, E X P 11, E X P 15, E X P 24, E X P 12, E X P 18 underscore 2, E X P 09, E X P 10, E X P 28, E X P 18 underscore 1, E X P 14, E X P 03, E X P 06, E X P 26 underscore 1, E X P 30, E X P 27 underscore 2, E X P 13, E X P 07, E X P 25, E X P 26 underscore 2, E X P 29, E X P 23, E X P 02, E X P 17, E X P 16, E X P 27 underscore 1, E X P 20, E X P 01, and E X P 19 (y-axis) across Cluster 1: E X P 21; Cluster 2: E X P 05, E X P 04, E X P 11, E X P 15; and Cluster 3: E X P 24, E X P 12, E X P 18 underscore 2, E X P 09, E X P 10, E X P 28, E X P 18 underscore 1, E X P 14, E X P 03, E X P 06, E X P 26 underscore 1, E X P 30, E X P 27 underscore 2, E X P 13, E X P 07, E X P 25, E X P 26 underscore 2, E X P 29, E X P 23, E X P 02, E X P 17, E X P 16, E X P 27 underscore 1, E X P 20, E X P 01, and E X P 19 (x-axis). A scale is ranging from 0.0 to 0.4 in increments of 0.09. Figure 1D is a horizontal bar graph, plotting EX P 26 underscore plate 1, EX P 27 underscore plate 2, EX P 30, EX P 13, EX P 25, EX P 03, EX P 06, EX P 07, EX P 26 underscore plate 2, EX P 29, EX P 14, EX P 27 underscore plate 1, EX P 20, EX P 01, EX P 09, EX P 19, EX P 18 underscore 2, EX P 24, EX P 12, EX P 15, EX P 11, EX P 04, EX P 05, and EX P 21 (y-axis) across Earth Mover’s Distance, ranging from 0.0 to 0.4 in increments of 0.09 (x-axis).

Quality control pipeline for ER distribution under control conditions. (A) Random fields of view of ER-immunolabeled, untreated MCF-7 breast cancer cells automatically imaged at 20×/0.75, shown as maximum intensity projection after image deconvolution. Scale bar: 20μm. (B) Heat map representation of the binned distribution of single cell ER levels across the indicated independent biological and technical replicates, with lower ER levels at the top and higher ER levels at the bottom of the heat map. (C) The distance between the ER distributions in two experiments was measured by earth mover’s distance (EMD), and the pairwise EMD distances were submitted to hierarchical clustering. The three main clusters “C1,” “C2,” and “C3” are indicated at the bottom of the heat map. (D) EMD distances calculated from the median ER distribution across all experiments in the main cluster from panel C. Experiments that deviated >3× standard deviations from the mean of the main cluster EMDs are identified according to the cluster map in panel C. The dotted line above EMD=0.1 represents three standard deviations from the mean of the main cluster (dotted line above approximately 0.05 EMD). Summary data for Figure 1B and D are found in Excel Tables S1 and S2, respectively. Note: EMD, earth mover’s distance; ER, estrogen receptor-α.